Experiences with Gamma-Encephalography

Ashkenazy M. Crawley J. W. : The value of serial studies of cerebro-vascular permeability with radio-active iodinated serum albumin and the scintillation counter particularly in the detection of neurosurgical lesions. Amer. Surg. 19 (1953), 155.

Bakay L. : The blood-brain barrier. Charles C. Thomas, Springfield, Illinois, U.S.A. 1956.

Belcher E. H. Evans H. D. De Winter J. G. : Use of radioactive di-iodofluorescein for the attempted localization of brain tumours. Brit. med. Bull. 8 (1952), 172.

Berne E. Jonsson H. : Ein magnetischer Analysator für die quantitative Auswertung von Scintigrammen. Nucl. Med. (Stuttg). 1 (1959), 80.

Blau M. Bender M. : Clinical evaluation of Hg²⁰³, Neohydrin and I¹³¹ albumin in brain tumour localization. J. Nuc. Med. 1 (1960), 106.

Blau M. Bender M. : Radiomercury (Hg²⁰³) labeled Neohydrin: A new agent for brain tumour localization. J. nucl. Med. 3 (1963), 106.

Brownell G. L. Sweet W. H. : Localization of brain tumours with positron emitters. Nucleonics 11 (1953), 3.

Bodforss B. Olin T. : Personal communication.

Cramer H. Pabst M. W. Treibs A. : Über die Verwendbarkeit radioaktiver Farbstoffe in der Tumordiagnostik, Z. Krebsforsch. 58 (1952), 433.

Di Chiro G. : RISA encephalography and conventional neuroradiological methods. Acta radiol. (1961) Suppl. No. 201.

Dunbar H. S. Ray B. S. : Localization of brain tumours and other intracranial lesions with radioactive iodinated human serum albumin. Surg. Gynec. Obstet. 98 (1954), 443.

Edström R. Berne E. : Radioactive brain tumour scanning, memorized and played back with stepwise impulse suppressor. Acta psychiat. scand. 37 (1961), 129.

Govoni A. : Esperieze cliniche sull'impiego di iodu radio-attivo unito a siero-albumine umana (RISHA) nella localisatione di processo pathologico endocranii. Nant. radiol 21 (1955), 788.

Long R. G. McAfee J. G. Winkelman J. : Evaluation of radioactive compounds for the external detection of cerebral tumours. Cancer Res. 23 (1963), 98.

Moore G. E. : Fluorescein as an agent in the differentiation of normal and malignant tissues. Science 106 (1947), 130.

Moore G. E. : Use of radioactive di-iodofluorescein in the diagnosis of and localization of brain tumours. Science 107 (1948), 569.

Moore G.E. Smith G. A. Candill C. M. et coli: Clinical and experimental studies of intracranial tumours with fluorescein dyes with an additional note concerning the possible use of K⁴² and I¹³¹ tagged human albumin. Amer. J. Roentgenol. 66 (1951), 1.

Morley T. P. Jefferson G. : Use of radioactive phosphorus in mapping brain tumours at operation. Brit. med. J. 2 (1952), 575.

Mundinger F. : The localisation of brain tumours by means of radioisotopes. Centrex Publishing Company, Eindhoven 1962.

Peyton W. T. Moore G. E. French L. A. Chou S. N. : Localization of intracranial lesions with radioactive isotopes. J. Neurosurg. 9 (1952), 443.

Planiol T. : Diagnostic des lésions intracraniennes par les radioisotopes. Masson et Cie, Paris 1959.

Schleisinger E. B. DeBores S. Taveras J. : Localization of brain tumours using radio-iodinated human serum albumin. Amer. J. Roentgenol. 87 (1962), 449.

Shy G. M. Bradley R. B. Mathews W. B. : External collimation detection of intracranial neoplasia with unstable nuclides. Livingstone, Edinburg 1958.

Sjögren S. E. : Experiences in localization of brain tumours by means of di-iodo-¹³³ fluorescein. Acta radiol. 40 (1953), 356.

Tauxe W. N. Sedlack R. E. Pitlyk P. J. Le Kerr F. W. : Preliminary report on the localization of brain lesions with I¹³¹-labeled polyvinylpyrrolidone. Proc. Mayo Clin. 37 (1962), 111.

Wende S. : Ergebnisse der Hirntumor — Diagnostik mit radioaktiven Substanzen. Acta radiol. Diagnosis 1 (1963), 972.

Wende S. : Teknik und Wert der Gamma-Encephalographie. Fortschr. Röntgenstr. 98 (1963), 466.

De Winter J. : Some preliminary clinical observations on the use of radioactive isotopes. for the localization of brain tumours. Brit. J. Radiol. 24 (1951), 280.